Alan T. Yeo

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

Ryohei Katayama, Alice T. Shaw, Tahsin Khan et al. · Science Translational Medicine · 2012 · 1.3K citations

Medicine, Oncology, Pharmacology +17

Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression

Alan T. Yeo, Shruti Rawal, Bethany Delcuze et al. · Nature Immunology · 2022 · 297 citations · Full text

Medicine, Immunology, Oncology +17

Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer

Anthony C. Faber, Anna F. Farago, Carlotta Costa et al. · Proceedings of the National Academy of Sciences · 2015 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

mTOR Inhibition Specifically Sensitizes Colorectal Cancers with <i>KRAS</i> or <i>BRAF</i> Mutations to BCL-2/BCL-XL Inhibition by Suppressing MCL-1

Anthony C. Faber, Erin M. Coffee, Carlotta Costa et al. · Cancer Discovery · 2013 · 127 citations · Full text

Medicine, Oncology, Pharmacology +17

Failure to Induce Apoptosis via BCL-2 Family Proteins Underlies Lack of Efficacy of Combined MEK and PI3K Inhibitors for KRAS-Mutant Lung Cancers

Aaron N. Hata, Alan T. Yeo, Anthony C. Faber et al. · Cancer Research · 2014 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17